Literature DB >> 26897640

Relationship Between Exercise Workload During Cardiac Rehabilitation and Outcomes in Patients With Coronary Heart Disease.

Clinton A Brawner1, Khaled Abdul-Nour2, Barry Lewis2, John R Schairer2, Shalini S Modi2, Dennis J Kerrigan2, Jonathan K Ehrman2, Steven J Keteyian2.   

Abstract

The purpose of this retrospective, observational study was to describe the relation between exercise workload during cardiac rehabilitation (CR), expressed as metabolic equivalents of task (METs), and prognosis among patients with coronary heart disease. We included patients with coronary heart disease who participated in CR between January 1998 and June 2007. METs were calculated from treadmill workload. Cox regression analysis was used to describe the relationship between METs and time to a composite outcome of all-cause mortality, nonfatal myocardial infarction, or heart failure hospitalization. Among 1,726 patients (36% women; median age 59 years [interquartile range, 52 to 66]), there were 467 events (27%) during a median follow-up of 5.8 years (interquartile range, 2.6 to 8.7). In analyses adjusted for age, sex, Charlson co-morbidity index, hypertension, diabetes, and CR referral diagnosis, METs were independently related to the composite outcome at CR start (Wald chi-square 43, hazard ratio 0.59 [95% confidence interval 0.51 to 0.70]) and CR end (Wald chi-square 47, hazard ratio 0.68 [95% confidence interval 0.61 to 0.76]). Patients exercising below 3.5 METs on exit from CR represent a high-risk group with 1- and 3-year event rates ≥7% and ≥18%, respectively. In conclusion, METs during CR is available at no additional cost and can be used to identify patients at increased risk for an event who may benefit from closer follow-up, extended length of stay in CR, and/or participation in other strategies aimed at maximizing adherence to secondary preventive behaviors and improving exercise capacity.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 26897640     DOI: 10.1016/j.amjcard.2016.01.018

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

1.  Examination of clinical and psychosocial determinants of exercise capacity change in cardiac rehabilitation.

Authors:  Emily C Gathright; Carly M Goldstein; Eric B Loucks; Andrew M Busch; Loren Stabile; Wen-Chih Wu
Journal:  Heart Lung       Date:  2018-08-06       Impact factor: 2.210

2.  Exercise Prescription Methods and Attitudes in Cardiac Rehabilitation: A NATIONAL SURVEY.

Authors:  Quinn R Pack; Meredith Shea; Clinton A Brawner; Samuel Headley; Jasmin Hutchinson; Hayden Madera; Steven J Keteyian
Journal:  J Cardiopulm Rehabil Prev       Date:  2022-02-18       Impact factor: 3.646

3.  Translation of an evidence-based therapeutic exercise program for patients with peripheral artery disease.

Authors:  Dereck L Salisbury; Mary O Whipple; Marsha Burt; Rebecca J L Brown; Alan Hirsch; Christopher Foley; Diane Treat-Jacobson
Journal:  J Vasc Nurs       Date:  2017-11-01

4.  A Comparison of Exercise Intensity in Hybrid Versus Standard Phase Two Cardiac Rehabilitation.

Authors:  Steven J Keteyian; Crystal Grimshaw; Clinton A Brawner; Dennis J Kerrigan; Lisa Reasons; Robert Berry; Edward L Peterson; Jonathon K Ehrman
Journal:  J Cardiopulm Rehabil Prev       Date:  2021-01-01       Impact factor: 3.646

5.  Exercise Prescription Guidelines for Cardiovascular Disease Patients in the Absence of a Baseline Stress Test.

Authors:  Megan Mytinger; Rachael K Nelson; Micah Zuhl
Journal:  J Cardiovasc Dev Dis       Date:  2020-04-27

6.  The Influence of Exercise Workload Progression Across 36 Sessions of Cardiac Rehabilitation on Functional Capacity.

Authors:  Truman Haeny; Rachael Nelson; Jeremy Ducharme; Micah Zuhl
Journal:  J Cardiovasc Dev Dis       Date:  2019-09-06

7.  Exercise Prescription and Progression Practices among US Cardiac Rehabilitation Clinics.

Authors:  Joesi Krieger; Nicholas McCann; Markaela Bluhm; Micah Zuhl
Journal:  Clin Pract       Date:  2022-03-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.